Audience-funded nonprofit news
Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
Once unheard-of, mentioning suicide as a cause of death in news obituaries and paid death notices has become more frequent especially in the past 10 years. High-profile suicides — such as those of comic actor Robin Williams in 2014, fashion designer Kate Spade in 2018, and dancer Stephen “tWitch” Boss in 2022 — have helped reduce the stigma surrounding suicide loss.
-
California has the most Chagas cases of any state.
-
Shots will show up in pharmacies in October.
-
Street psychiatry is a burgeoning field in L.A. But is it enough to help the thousands of Angelenos who live with severe mental illness?
-
Guidance for parents from the district and a pediatrician as we head into the third school year with COVID.
-
A new proposal from the Centers for Medicare & Medicaid Services offers more support to people who care for frail, ill, and disabled older adults.
-
Support groups help manage the strain on caregivers in the epicenter of Alzheimer’s cases.
-
The Biden administration wants to crack down on private arrangements among some hospitals to reimburse themselves for taxes that help fund coverage for low-income people.
-
Two of the three troubled California hospitals are especially vital to their communities because they’re the only emergency providers in their rural counties. Health care chains could keep them afloat.
-
The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment.
-
Individual health care facilities may maintain a masking policy.
-
California law requires Medi-Cal and all other state-regulated health plans to cover gender-affirming care that is deemed medically necessary. But therein lies the rub.
